Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07318285
Targeted Lidocaine Infusion for Pain Reduction in Office Hysteroscopy (OPTILID)
A Modified Technique of Target Lidocaine Infusion for Pain Control in Office Hysteroscopy: A Double-Blind Randomized Controlled
Sponsor: YAARA TABIB
Interventions
Lidocaine %2 ampoule Saline (0.9% NaCl)
Updated 1 time since 2026 Last updated: Dec 28, 2025 Started: Feb 1, 2026 Primary completion: Dec 30, 2028 Completion: Dec 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Hysteroscopy / Methods and Lidocaine Infusion, this trial is actively recruiting participants. The trial is conducted by YAARA TABIB and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- YAARA TABIB
Data source: Hadassah Medical Organization
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.